Press Releases

BURLINGTON, Vt., May 31 – A plan by the Koch brothers, a right-wing conservative family, to spend $400 million on political campaigns this year is the latest evidence of the need to overturn a Supreme Court ruling that voided campaign finance laws, U.S. Sen. Bernie Sanders (I-Vt.) said today. Organizations related to Charles and David Koch, the billionaires who run

BURLINGTON, Vt., May 26 – U.S. Sen. Bernie Sanders (I-Vt.) is participating in Memorial Day events throughout Vermont this weekend and issued the following statement: “On Memorial Day, a grateful nation pays tribute to those who died while in service to our country.  We are extremely proud of the generations of veterans from the Green Mountain Boys in the Revolutionary War

The U.S. Senate Thursday night confirmed the Adjutant General of the Vermont National Guard, Major General Michael Dubie, to a top post in the U.S. military’s homeland defense mission.  General Dubie, nominated by President Obama, will be the Deputy Commander of the United States Northern Command (NORTHCOM), the military’s unified command in charge of protecting U.S. territory and providing military

WASHINGTON, May 24 – Sen. Bernie Sanders (I-Vt.) issued the following statement today after the Senate voted on a Food and Drug Administration bill: “The most pressing prescription drug issue in our country today is that Americans pay, by far, the highest prices in the world for their medicine and millions of people cannot afford the medications their doctors prescribe.  I voted against this

WASHINGTON, May 24 – Sen. Bernie Sanders (I-Vt.) issued the following statement on the nomination of Allison Macfarlane to chair the Nuclear Regulatory Commission. “By all accounts Dr. Macfarlane has the qualifications and credentials to lead the Nuclear Regulatory Commission. I believe we need someone who is dedicated to safety reforms and openness at the NRC, and who understands that the commission’s role is to

WASHINGTON, May 23 – Sen. Bernie Sanders (I-Vt.) today proposed tough new penalties to combat rampant pharmaceutical industry fraud. Sanders’ amendment to a Food and Drug Administration bill before the Senate would take away exclusive marketing rights – potentially worth hundreds of millions of dollars – if a company is found to be at fault for fraud involving a particular drug. “Companies that are fined for overcharging